Martin Henrichs

Managing Director - Head of Healthcare EMEA

UBS

Martin is an investment banker who has specialised in the healthcare sector for more years than he cares to remember. He has completed a large number of advisory and financing transactions for leading healthcare companies such as Affidea, Fresenius, IDH, IHH, Korian-Medica, Labco, Life Healthcare, Mediclinic, Priory and Rhön-Klinikum, with cumulative transaction volumes in excess of $100 billion. Despite his German roots, French and Italian were actually his first main languages, given he has lived and grown up in 7 countries on 3 different continents.

Hear me speak at HBI

5:00 pmPlenary

What we Learned at HBI 2022

What are the main insights and learnings from HBI 2022? Martin Henrichs of UBS and Max Hotopf, HBI founder, talks about the key takeaways this year in terms of new...

Martin HenrichsManaging Director - Head of Healthcare EMEAUBS

Max HotopfFounder & ChairmanHBI

10:00 amInvestment M&A

Investing in Europe

What do investors think about key sectors and valuations in Europe? How are concerns about increasing inflation rates impacting valuations? What impact are the ongoing healthcare reforms in the wake...

Martin HenrichsManaging Director - Head of Healthcare EMEAUBS